Your browser doesn't support javascript.
loading
In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia.
Xiao, Guangqing; Chen, Yu-Luan; Dedic, Nina; Xie, Linghong; Koblan, Kenneth S; Galluppi, Gerald R.
Afiliação
  • Xiao G; DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA. guangqing.xiao@sunovion.com.
  • Chen YL; DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
  • Dedic N; DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
  • Xie L; DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
  • Koblan KS; DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
  • Galluppi GR; DMPK and Clinical Pharmacology, Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA, 01752, USA.
Pharm Res ; 39(5): 837-850, 2022 May.
Article em En | MEDLINE | ID: mdl-35484370
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Receptor 5-HT1A de Serotonina Limite: Animals Idioma: En Revista: Pharm Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Receptor 5-HT1A de Serotonina Limite: Animals Idioma: En Revista: Pharm Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos